3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Myeloid
1
CNS
1
Conditions
Lymphoma
24
Lymphoma, Non-Hodgkin
15
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14
Lymphoma, Large B-Cell, Diffuse
13
Leukemia, Myeloid, Acute
9
Leukemia
9
Neuroblastoma
8
Leukemia, Lymphocytic, Chronic, B-Cell
8
Hodgkin Disease
8
Central Nervous System Neoplasms
8
Medulloblastoma
7
Rhabdoid Tumor
6
Recurrence
6
Multiple Myeloma
6
Lymphoma, Mantle-Cell
6
Lymphoma, Large-Cell, Immunoblastic
6
Lymphoma, B-Cell, Marginal Zone
6
Burkitt Lymphoma
6
Neoplasms, Germ Cell and Embryonal
5
Lymphoma, Follicular
5
Lymphoma, B-Cell
5
Glioma
5
Brain Neoplasms
5
Sarcoma
4
Ovarian Neoplasms
4
Oligodendroglioma
4
Neoplasms
4
Lung Neoplasms
4
Immunoblastic Lymphadenopathy
4
Astrocytoma
4
Interventions
Cyclophosphamide
16
Temozolomide
13
Vincristine
10
Irinotecan
8
Melphalan
7
Doxorubicin
7
Topotecan
6
Granulocyte Colony-Stimulating Factor
6
Busulfan
6
fludarabine
5
cabozantinib
5
Etoposide
5
Drug Therapy
5
liposomal doxorubicin
4
Sirolimus
4
Ifosfamide
4
Filgrastim
4
regorafenib
3
pegfilgrastim
3
irinotecan sucrosofate
3
fludarabine phosphate
3
Zoledronic Acid
3
Radiotherapy
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Gemcitabine
3
Cisplatin
3
Bone Marrow Transplantation
3
Albumin-Bound Paclitaxel
3
pegylated granulocyte colony-stimulating factor
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Sarcoma, Ewing
×
etoposide phosphate
×
Clear all
NCT02574728
2026-03-02
AflacST1502
Emory University
Phase 2
Active not recruiting
46 enrolled